youtube_live
Q3 2026 earnings • released • EPS beat +14.76% • Revenue beat +0.28%
See resultschevron_right
ENOV:NYSE
Enovis Corp
$27.16
arrow_downward
-5.10%(-1.46) 1D
$27.16
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 6, 4:00:03 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ENOV...
Open
$27.24
High
$27.67
Low
$26.62
Mkt. cap
1.57B
Avg. vol.
1.70M
Volume
2.30M
52-wk high
$32.41
52-wk low
$16.70
EPS
-$9.22
Beta
1.08
Shares outstanding
57.67M
No. of employees
8K
Open
$27.24
High
$27.67
Low
$26.62
Mkt. cap
1.57B
Avg. vol.
1.70M
Volume
2.30M
52-wk high
$32.41
52-wk low
$16.70
EPS
-$9.22
Beta
1.08
Shares outstanding
57.67M
No. of employees
8K
News stories
From web sources and news partners
GuruFocus
·
5 hours ago
ENOV Maintains By Canaccord Genuity -- Price Target Lowered to $42
GuruFocus
·
10 hours ago
ENOV Maintained by Evercore ISI Group -- Price Target Raised to $33
StreetInsider
·
1 day ago
Enovis Corporation (ENOV) Tops Q3 EPS by 11c ; Offers Guidance
TradingView
·
1 day ago
Why are Enovis (ENOV) shares soaring today
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOMatthew L. Trerotola
Employees7.8K
Founded1995
HeadquartersWilmington, Delaware, United States
SectorHealth Care
IndustryMedical device
Websiteenovis.com
Analyst ratings
Based on 10 analysts giving stock ratings to ENOV in the past 3 months
Strong buy
Buy
9
Hold
1
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for ENOV in the last 3 months.
Highest
Current $27.16
$47.00 (+73.05%)
Average
$37.89 (+39.51%)
Lowest
$28.00 (+3.09%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Vik Chopra BMO Capital | Buy | Maintained | $31.00 | +14.1% | 11/06/2026 |
Caitlin Cronin Canaccord Genuity | Buy | Reiterated | $42.00 | +54.6% | 11/06/2026 |
Larry Biegelsen Wells Fargo | Buy | Reiterated | $37.00 | +36.2% | 11/06/2026 |
Ryan Zimmerman BTIG | Buy | Maintained | $42.00 | +54.6% | 11/05/2026 |
Michael Matson Needham | Buy | Maintained | $34.00 | +25.2% | 10/12/2026 |
Patrick Wood UBS | Buy | Maintained | $44.00 | +62% | 10/05/2026 |
Caitlin Roberts Canaccord Genuity | Buy | Reiterated | $45.00 | +65.7% | 09/01/2026 |
David Turkaly Citizens JMP | Buy | Maintained | $47.00 | +73% | 09/02/2026 |
Keith Hinton Freedom Capital Markets | Buy | Maintained | $36.00 | +32.5% | 09/01/2026 |
Steven Lichtman William Blair | Buy | Maintained | - | - | 08/14/2026 |
Robbie Marcus J.P. Morgan | Hold | Maintained | $28.00 | +3.1% | 08/10/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $32.00 | +17.8% | 08/07/2026 |
Rong Li Jefferies | Buy | Reiterated | $40.00 | +47.3% | 07/14/2026 |
Unknown Analyst Jefferies | Buy | Reiterated | $40.00 | +47.3% | 07/14/2026 |
Unknown Analyst BMO Capital | Buy | Initiated | $29.00 | +6.8% | 07/09/2026 |
Jeff Johnson Robert W. Baird | Buy | Maintained | $37.00 | +36.2% | 05/08/2026 |
Last report
Nov 5, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.88 / $0.77
+14.76%beat
arrow_upward
Revenue / Est. (USD)
558.72M / 557.15M
+0.28%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Oct 2025 | Dec 2025 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
Revenue | 548.91M | 575.76M | 589.15M | 582.78M |
Cost of goods sold | 218.50M | 222.69M | 223.67M | 223.53M |
Cost of revenue | 218.50M | 222.69M | 223.67M | 223.53M |
Research and development expenses | 29.74M | 31.36M | 31.53M | 31.69M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 245.42M | 249.84M | 270.58M | 261.61M |
Operating expense | 318.85M | 326.38M | 344.02M | 334.86M |
Total operating expenses | 537.35M | 549.08M | 567.69M | 558.39M |
Operating income | 11.56M | 26.68M | 21.46M | 24.39M |
Other non operating income | 448.00K | 1.93M | 3.27M | -1.91M |
EBT including unusual items | -566.87M | -509.55M | 634.00K | 7.46M |
EBT excluding unusual items | 3.18M | 21.10M | 15.57M | 14.44M |
Income tax expense | 4.00M | 9.26M | 9.04M | 8.50M |
Effective tax rate | -0.71% | -1.82% | 1,426.66% | 113.88% |
Other operating expenses | - | - | - | - |
Net income | -571.15M | -520.59M | -8.76M | -1.19M |
Net profit margin | -104.05% | -90.42% | -1.49% | -0.20% |
Earnings per share | 0.75 | 0.95 | 0.89 | 0.90 |
Interest and investment income | 12.00M | 12.60M | 10.00M | 10.50M |
Interest expense | -20.83M | -20.11M | -19.17M | -18.54M |
Net interest expenses | -8.83M | -7.51M | -9.17M | -8.04M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 85.94M | 103.69M | 94.82M | 95.42M |
Gain or loss from assets sale | 281.00K | 329.00K | -75.00K | 843.00K |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events